Metabolomic and Mass Isotopomer Analysis of Liver Gluconeogenesis and Citric Acid Cycle

Lili Yang, Rajan S. Kombu, Takhar Kasumov, Shuhan Zhu, Andrea V. Cendrowski, France David, Vernon Anderson, Joanne K. Kelleher, Henri Brunengraber

Journal of Biological Chemistry · 2008 · 47 citations · 43 references

DOIFull text

Open access

Concepts

Abstract

We conducted a study coupling metabolomics and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. Rat livers were perfused with lactate or pyruvate ± aminooxyacetate or mercaptopicolinate in the presence of 40% enriched NaH13CO3. Other livers were perfused with dimethyl [1,4-13C2]succinate ± mercaptopicolinate. In this first of two companion articles, we show that a substantial fraction of gluconeogenic carbon leaves the liver as citric acid cycle intermediates, mostly α-ketoglutarate. The efflux of gluconeogenic carbon ranges from 10 to 200% of the rate of liver gluconeogenesis. This cataplerotic efflux of gluconeogenic carbon may contribute to renal gluconeogenesis in vivo. Multiple crossover analyses of concentrations of gluconeogenic intermediates and redox measurements expand previous reports on the regulation of gluconeogenesis and the effects of inhibitors. We also demonstrate the formation of adducts from the condensation, in the liver, of (i) aminooxyacetate with pyruvate, α-ketoglutarate, and oxaloacetate and (ii) mercaptopicolinate and pyruvate. These adducts may exert metabolic effects unrelated to their effect on gluconeogenesis. We conducted a study coupling metabolomics and mass isotopomer analysis of liver gluconeogenesis and citric acid cycle. Rat livers were perfused with lactate or pyruvate ± aminooxyacetate or mercaptopicolinate in the presence of 40% enriched NaH13CO3. Other livers were perfused with dimethyl [1,4-13C2]succinate ± mercaptopicolinate. In this first of two companion articles, we show that a substantial fraction of gluconeogenic carbon leaves the liver as citric acid cycle intermediates, mostly α-ketoglutarate. The efflux of gluconeogenic carbon ranges from 10 to 200% of the rate of liver gluconeogenesis. This cataplerotic efflux of gluconeogenic carbon may contribute to renal gluconeogenesis in vivo. Multiple crossover analyses of concentrations of gluconeogenic intermediates and redox measurements expand previous reports on the regulation of gluconeogenesis and the effects of inhibitors. We also demonstrate the formation of adducts from the condensation, in the liver, of (i) aminooxyacetate with pyruvate, α-ketoglutarate, and oxaloacetate and (ii) mercaptopicolinate and pyruvate. These adducts may exert metabolic effects unrelated to their effect on gluconeogenesis. Although hypothesis-based research is the gold standard of biological investigation, it is necessary from time to time to expand its scope by a period of data-based discovery research. The current omic revolution is fulfilling this need. By widening the knowledge base, omics and in particular metabolomics (1Soga T. Baran R. Suematsu M. Ueno Y. Ikeda S. Sakurakawa T. Kakazu Y. Ishikawa T. Robert M. Nishioka T. Tomita M.J. J. Biol. Chem. 2006; 281: 16768-16776Abstract Full Text Full Text PDF PubMed Scopus (557) Google Scholar, 2Kell D.B. Oliver S.G. BioEssays. 2004; 26: 99-105Crossref PubMed Scopus (409) Google Scholar, 3Rochfort S. J. Nat. Prod. 2005; 68: 1813-1820Crossref PubMed Scopus (354) Google Scholar, 4Weckwerth W. Loureiro M.E. Wenzel K. Fiehn O. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 7809-7814Crossref PubMed Scopus (317) Google Scholar, 5Weckwerth W. Morgenthal K. Drug Discov. Today. 2005; 10: 1551-1558Crossref PubMed Scopus (236) Google Scholar) identify unknown correlations, allowing the formulation and testing of new hypotheses. We hypothesized that the scope of metabolomics could be enhanced by associating it with mass isotopomer analysis, a powerful technique developed over the past 16 years (reviewed in Refs. 6Hellerstein M.K. Neese R.A. Am. J. Physiol. 1999; 276: E1146-E1170Crossref PubMed Google Scholar, 7Brunengraber H. Kelleher J.K. Des Rosiers C. Annu. Rev. Nutr. 1997; 17: 559-596Crossref PubMed Scopus (94) Google Scholar). This association would allow the identification of unexpected labeling patterns of metabolites, pointing to unknown reactions and/or regulatory mechanisms (8Fridman E. Pichersky E. Curr. Opin. Plant Biol. 2005; 8: 242-248Crossref PubMed Scopus (107) Google Scholar). We used this association of techniques to expand our previous studies on the influence of metabolic zonation of the liver on the labeling patterns of metabolites and on metabolic rates calculated from these labeling patterns. Over the past 12 years, questions were raised on the potential influence of the metabolic zonation of the liver (9Jungermann K. Diabetes Metab. Rev. 1987; 3: 269-293Crossref PubMed Scopus (59) Google Scholar) on the 13C-labeling pattern of glucose released by gluconeogenesis (GNG), 2The abbreviations used are: GNGgluconeogenesisαGPα-glycerophosphateAOAaminooxyacetateDHAPdihydroxyacetone phosphateCACcitric acid cycleMIDmass isotopomer distributionMPAmercaptopicolinateOAAoxaloacetatePEPphosphoenolpyruvatePEPCKphosphoenolpyruvate carboxykinaseTMStrimethylsilylGC-MSgas chromatography-mass spectrometryLC-MS/MSliquid chromatography-tandem mass spectrometryHPLChigh pressure liquid chromatography. glycogenolysis, or both. The zonated structure of the liver results in translobular gradients of enzyme activities and of blood substrate concentrations (glycerol, acetate, and NH+4) (10Previs S.F. Fernandez C.A. Yang D. Soloviev M.V. David F. Brunengraber H. J. Biol. Chem. 1995; 270: 19806-19815Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar, 11Puchowicz M.A. Bederman I.R. Comte B. Yang D. David F. Stone E. Jabbour K. Wasserman D.H. Brunengraber H. Am. J. Physiol. 1999; 277: E1022-E1027PubMed Google Scholar, 12Yang D. Hazey J.W. David F. Singh J. Rivchum R. Streem J.M. Halperin M.L. Brunengraber H. Am. J. Physiol. 2000; 278: E469-E476Crossref PubMed Google Scholar). Also, the computation of the mass isotopomer distribution (MID) of (i) glucose labeled from [13C]glycerol or (ii) fatty acids and sterols labeled from [13C]acetate revealed the occurrence of translobular gradients of enrichment of triose phosphates or lipogenic acetyl-CoA, respectively (10Previs S.F. Fernandez C.A. Yang D. Soloviev M.V. David F. Brunengraber H. J. Biol. Chem. 1995; 270: 19806-19815Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar, 13Landau B.R. Fernandez C.A. Previs S.F. Ekberg K. Chandramouli V. Wahren J. Kalhan S.C. Brunengraber H. Am. J. Physiol. 1995; 269: E18-E26PubMed Google Scholar, 14Bederman I.R. Reszko A.E. Kasumov T. David F. Wasserman D.H. Kelleher J.K. Brunengraber H. J. Biol. Chem. 2004; 279: 43207-43216Abstract Full Text Full Text PDF PubMed Scopus (30) Google Scholar). This results in underestimations of fractional rates of glucose, fatty acid, and sterol synthesis calculated from the MID of these compounds synthesized from a 13C-labeled substrate. In this study, we hypothesized that the metabolic zonation of the liver might result in incompatible labeling of intermediates extracted from the whole liver. Such incompatibilities were suggested in 1970 by Veneziale et al. (15Veneziale C.M. Gabrielli F. Lardy H.A. Biochemistry. 1970; 9: 3960-3970Crossref PubMed Scopus (34) Google Scholar). In livers perfused with [2-14C]pyruvate and quinolinate, an inhibitor of phosphoenolpyruvate carboxykinase (PEPCK), they observed substantial differences in the labeling of PEP and 3-phosphoglycerate. We also hypothesized that the extra-mitochondrial metabolism of citric acid cycle (CAC) intermediates would affect their labeling pattern and result in differences in the labeling patterns of tissue and extracellular metabolites. We tested these hypotheses by combining metabolomics with the determination of MIDs of gluconeogenic and CAC intermediates. gluconeogenesis α-glycerophosphate aminooxyacetate dihydroxyacetone phosphate citric acid cycle mass isotopomer distribution mercaptopicolinate oxaloacetate phosphoenolpyruvate phosphoenolpyruvate carboxykinase trimethylsilyl gas chromatography-mass spectrometry liquid chromatography-tandem mass spectrometry high pressure liquid chromatography. We perfused rat livers with 13C-substrates, the label of which is channeled to [1-13C]PEP before entering GNG. One substrate was NaH13CO3, which labels liver GNG from lactate or pyruvate via carboxylation and isotopic exchange reactions (16Esenmo E. Chandramouli V. Schumann W.C. Kumaran K. Wahren J. Landau B.R. Am. J. Physiol. 1992; 263: E36-E41PubMed Google Scholar). The second substrate was dimethyl [1,4-13C2]succinate, which labels PEP via reactions of the citric acid cycle and PEPCK. We modulated the rates of GNG from lactate, pyruvate, or [1,4-13C2]succinate using mercaptopicolinate (MPA), an inhibitor of PEPCK (17Blackshear P.J. Holloway P.A. Alberti K.G. Biochem. J. 1975; 148: 353-362Crossref PubMed Scopus (43) Google Scholar, 18Jomain-Baum M. Schramm V.L. Hanson R.W. J. Biol. Chem. 1976; 251: 37-44Abstract Full Text PDF PubMed Google Scholar), or aminooxyacetate (AOA), an inhibitor of the glutamate-aspartate shuttle (19Rognstad R. Clark D.G. Arch. Biochem. Biophys. 1974; 161: 638-646Crossref PubMed Scopus (69) Google Scholar, 20Ochs R.S. Harris R.A. Biochim. Biophys. Acta. 1980; 632: 260-269Crossref PubMed Scopus (18) Google Scholar, 21Cornell N.W. Zuurendonk P.F. Kerich M.J. Straight C.B. Biochem. J. 1984; 220: 707-716Crossref PubMed Scopus (54) Google Scholar). In this first of two companion articles, we show that a substantial fraction of gluconeogenic carbon leaves the liver as α-ketoglutarate and other CAC intermediates. Also our data reveal the formation of methoxamates from AOA and ketoacids. Materials—General chemicals, biochemicals, and enzymes were obtained from Sigma. Mercaptopicolinic acid was obtained from Apin Chemical Ltd. (UK), and pentafluorobenzyl bromide was from Pierce. [13C6]Citric, [1,5-13C2]citric, and [13C4]succinic acids, phosphoenol[1-13C]pyruvate (99%), K13CN (99%), [2H5]glycerol, 2H2O, and NaO2H (98%) were purchased from Isotec (Miamisburg, OH). [1,4-13C2]Succinic acid (99%) and NaB2H4 (99%) were purchased from Cambridge Isotope Laboratories. An internal standard of (RS)-3-hydroxy-[2H5]glutarate was prepared by isotopic exchange of acetone dicarboxylic diethyl ester in 2H2O and NaO2H, followed by reduction with NaB2H4, and extraction in acid. This procedure is similar to that previously used for the preparation of (RS)-3-hydroxy-[2H5]butyrate from acetoacetate (22Des Rosiers C. Montgomery J.A. Desrochers S. Garneau M. David F. Mamer O.A. Brunengraber H. Anal. Biochem. 1988; 173: PubMed Scopus Google Scholar). acid was prepared by acetone dicarboxylic diethyl ester with followed by of the The of the synthesized compounds was by of trimethylsilyl [1,4-13C2]succinate was prepared by the acid with The or acid. of and were prepared from using α-glycerophosphate and The of pyruvate, and α-ketoglutarate were prepared as by and E. J. Am. Chem. Scopus Google Scholar) for pyruvate was by of the The was prepared by mercaptopicolinate and pyruvate in for The was extracted with diethyl to its and by The of the was to the synthesis was conducted with a were of the of the which to its were for on from were first perfused H. M. J.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar) for 10 with substrate. they were perfused with (i) 40% enriched and lactate, or pyruvate ± or AOA or (ii) dimethyl [1,4-13C2]succinate ± In we that the labeling of gluconeogenic and CAC intermediates, as as glucose were two to with dimethyl [1,4-13C2]succinate with [1,4-13C2]succinate in glucose from and were by R. Arch. Biochem. Biophys. 1984; PubMed Scopus Google Scholar). we conducted the of this with dimethyl [1,4-13C2]succinate ± the mercaptopicolinate a we to the of in the with was the liver via a or the livers were and in liquid tissue with internal of of and of was extracted with of using a the the was in acetone by of of was to the and the extraction J. S. J.A. J. Biol. Chem. Full Text PDF PubMed Google was for The was for The was and with of to ketoacids. The was for with 10 of the the two were to with and in a The was with of with for to the and of the were on an mass to a gas with an a and an The gas was with a pressure of The was or The was and the The was as for by 10 to for The and the were The pressure was to we the the and labeled mass The MID of was with the The pattern of was in the of and to with the identification and to The concentrations and MIDs of compounds of were and in Kasumov T. David F. Previs S.F. Kelleher J.K. Brunengraber H. 2006; Scopus Google mass spectrometry of AOA adducts were on a mass to an The was a pressure of The gas was a pressure of The gas pressure was and the gas pressure was was V. potential was potential was was for enhanced mass potential was and was V. The were for for pyruvate for for α-ketoglutarate for for and for AOA with a time of was used for data and The was The analyses were on an was with was was with a rate of for By the was to and a rate of and for the was to and was for for a rate of concentrations of metabolites were calculated H. M. J.M. J. Biol. Chem. Full Text PDF PubMed Google Scholar) as in and the and The was used to concentrations as ± was tested by with was for studies were conducted in (i) measurements and of CAC intermediates and (ii) redox the of by crossover analysis B. J. Biol. Chem. Full Text PDF PubMed Google Scholar) of data as concentrations and for adducts of and aminooxyacetate or mercaptopicolinate in of citric acid cycle intermediates and of in livers were perfused with [1,4-13C2]succinate ± mercaptopicolinate. as ± redox and in perfused The calculated as to the of the lactate to the of gluconeogenic and citric acid cycle intermediates in livers perfused with pyruvate was with from of Kasumov T. David F. Previs S.F. Kelleher J.K. Brunengraber H. 2006; Scopus Google the effects of or AOA on the of gluconeogenic and citric acid cycle intermediates in livers perfused with lactate pyruvate. lactate lactate AOA pyruvate pyruvate. pyruvate AOA pyruvate. the effects of on the of gluconeogenic and citric acid cycle intermediates in livers perfused with dimethyl formation of adducts (i) AOA and pyruvate α-ketoglutarate or and (ii) and pyruvate of to the of with AOA or a of AOA was in the of the mass pyruvate was to the AOA The of pyruvate, and the in and of CAC and data from with lactate or pyruvate ± or of glucose of of CAC intermediates, and of The of CAC intermediates, and in the data for and with dimethyl [1,4-13C2]succinate ± The rates of glucose previous data as (i) of GNG from lactate, pyruvate, or by M. Schramm V.L. Hanson R.W. J. Biol. Chem. 1976; 251: 37-44Abstract Full Text PDF PubMed Google Scholar), and (ii) of GNG from lactate, pyruvate, by AOA (19Rognstad R. Clark D.G. Arch. Biochem. Biophys. 1974; 161: 638-646Crossref PubMed Scopus (69) Google Scholar, 20Ochs R.S. Harris R.A. Biochim. Biophys. Acta. 1980; 632: 260-269Crossref PubMed Scopus (18) Google Scholar). in and the livers released CAC intermediates, of which or was α-ketoglutarate The other CAC intermediates released in of and The livers also released and which the of CAC intermediates and In the of CAC intermediates as a result of the of GNG and and of the gluconeogenic carbon the liver as in in and/or to glucose in the J.M. H.A. Biochem. J. PubMed Scopus Google Scholar). This the of a of gluconeogenic Such may liver PEPCK and glucose S.C. M. M.A. PubMed Scopus Google Scholar). In these renal GNG is in by cataplerotic gluconeogenic intermediates released by the of CAC intermediates, and from perfused rat ± lactate ± ± ± ± ± lactate ± ± ± ± ± ± lactate ± ± ± ± ± ± ± pyruvate ± ± ± ± ± ± pyruvate ± ± ± ± ± ± ± pyruvate ± ± ± ± ± ± dimethyl ± ± ± ± ± ± ± dimethyl ± ± ± ± ± ± ± in a new rate of pyruvate carboxylation be in with lactate or pyruvate by the rates of glucose and the of CAC intermediates in by the first two of rate of pyruvate carboxylation be calculated as the of glucose of CAC intermediates, and of One the of and from of CAC intermediates. Although the labeling of and from was labeling could by isotopic of acids from with and α-ketoglutarate on this and in the Kasumov T. R.S. David F. Kelleher J.K. Brunengraber H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google In pyruvate carboxylation GNG by in the of inhibitor and and by to 200% in the presence of an inhibitor and Although PEPCK its of GNG from lactate or pyruvate to and in pyruvate carboxylation This effect from the of and to be In AOA effects on pyruvate carboxylation in with lactate from pyruvate from is in of the the of GNG by and/or AOA to a in the of the gluconeogenic lactate or pyruvate. The of the could be in our with high concentrations of In GNG is the of pyruvate carboxylation and of the of CAC intermediates is a that and of the concentrations of metabolites two redox and a of crossover analyses B. J. Biol. Chem. Full Text PDF PubMed Google Scholar) which and expand previous The tissue the in the the of is to the and The tissue a of the and We were to the which the of the of The redox in in to the of the lactate as The of these redox the (i) from the of and in two of of the lactate (ii) In the of the substrate and to the formation of which may with Kasumov T. R.S. David F. Kelleher J.K. Brunengraber H. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). first the of GNG from lactate by or AOA the in the In glucose from lactate was the by lactate was by The in the to a in the of pyruvate and This (i) a in the of lactate to pyruvate, and (ii) to the of GNG by in the by in the in the presence of or AOA previously in in livers (17Blackshear P.J. Holloway P.A. Alberti K.G. Biochem. J. 1975; 148: 353-362Crossref PubMed Scopus (43) Google Scholar) and in respectively R.S. Harris R.A. Biochim. Biophys. Acta. 1980; 632: 260-269Crossref PubMed Scopus (18) Google Scholar). The in the the the of was by or In with pyruvate, the carbon of is from to as the that to be used by H.A. V. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). of GNG by results in an of and an in the and In with pyruvate and GNG was the and for that The in the by in with be by the of PEPCK. is in the for the synthesis of glucose from the carbon of the as The for the of is the as from PEP pyruvate The in the results in the in the analysis was developed by B. J. Biol. Chem. Full Text PDF PubMed Google Scholar) to identify in metabolic to an that the the concentrations in of by of the and the concentrations of gluconeogenic intermediates in livers perfused with pyruvate lactate from lactate or pyruvate were similar and would that the of pyruvate was in the in the the of pyruvate for pyruvate is high D.B. J. Biol. Chem. Full Text PDF PubMed Google Scholar), other pyruvate GNG from lactate or pyruvate. the of liver pyruvate was in the presence of pyruvate We that of the pyruvate was in the extracellular the gluconeogenic intermediates pyruvate and which were also concentrations in livers perfused with pyruvate the rates of glucose were similar in glucose from pyruvate was by an enzyme other in Annu. Rev. Nutr. 1999; PubMed Scopus Google Scholar). that phosphates be with our technique Kasumov T. David F. Previs S.F. Kelleher J.K. Brunengraber H. 2006; Scopus Google Scholar). the effects of on GNG from lactate pyruvate The concentrations of gluconeogenic intermediates from pyruvate to triose phosphates were in the presence of pyruvate This the by of GNG from pyruvate from lactate and in the presence of pyruvate or lactate, a crossover and with the of GNG the of PEPCK M. Schramm V.L. Hanson R.W. J. Biol. Chem. 1976; 251: 37-44Abstract Full Text PDF PubMed Google Scholar, R. J. Biol. Chem. Full Text PDF PubMed Google Scholar) and similar crossover of data from an in was by et al. (17Blackshear P.J. Holloway P.A. Alberti K.G. Biochem. J. 1975; 148: 353-362Crossref PubMed Scopus (43) Google Scholar). the effects of AOA on GNG from lactate pyruvate. to current GNG from lactate the to of the carbon of as via the glutamate-aspartate This was (19Rognstad R. Clark D.G. Arch. Biochem. Biophys. 1974; 161: 638-646Crossref PubMed Scopus (69) Google Scholar) by that an GNG from lactate, from pyruvate GNG from pyruvate the glutamate-aspartate The effect of AOA on the concentrations of gluconeogenic intermediates in livers in AOA lactate AOA pyruvate and AOA lactate of the concentrations as for the In with pyruvate, the of AOA the concentrations of and α-ketoglutarate GNG was The of these is in GNG from pyruvate. Although the of was by AOA and the of α-ketoglutarate was 40% by AOA in with pyruvate Also, in with lactate, the of AOA the concentrations of and pyruvate GNG from lactate was by the in and pyruvate concentrations to a redox from the of by lactate the effect of on the of livers perfused with dimethyl ester The of the of CAC intermediates in livers perfused with to for and a crossover PEPCK. The in in the presence of GNG from was by GNG from lactate was and The high of in the presence of was the in the presence of pyruvate the of PEPCK by The crossover analyses of concentrations of gluconeogenic intermediates and the redox and expand previous reports on the regulation of gluconeogenesis and the effects of inhibitors. of and AOA or study the to a in by et al. J. Biochem. PubMed Scopus Google Scholar) on the of the of GNG from lactate by that AOA could a with pyruvate and the of pyruvate in liver the in glucose from lactate would result from the of and the of pyruvate. This was AOA GNG from in J. Biochem. PubMed Scopus Google Scholar, R. J. Biochem. J. 1970; PubMed Scopus Google Scholar). et al. J. Biochem. PubMed Scopus Google Scholar) that the effect of AOA would affect the of other and α-ketoglutarate which intermediates of GNG from Although the pyruvate synthesized in E. J. Am. Chem. Scopus Google Scholar), we could a its formation GNG is by this we first of AOA and pyruvate and we observed the formation of the The was extracted in acid and by of its of liver reveal the presence of the we synthesized the methoxamates of AOA with pyruvate, α-ketoglutarate, and their by their and the of their concentrations by This the of with the would the from their AOA The was in the of livers perfused it was in the of livers perfused with lactate AOA ± and pyruvate AOA ± In the of liver perfused with the mass of the was by mass over that in of livers perfused with lactate The data that the was in the and that its was pyruvate lactate as a substrate. we to the that in with lactate the might the the the livers were perfused with blood the time of the in the liver was the may of the liver. Also, in with pyruvate the before the the for the time of we conducted the in We a AOA from a the of the via an and a a of the was to the the of AOA and the the of pyruvate and of the we pyruvate to the and the time of the formation of the and of AOA of of pyruvate to the AOA Also, the formation to an of the pyruvate is This in with lactate the of the the liver. the was in liver tissue of which of the is extracellular This is the of liver was with to ketoacids. The liver which of was with of This the pyruvate from the the liver using would be an pyruvate and AOA could with in the the pyruvate in livers perfused with AOA a of the that formation would the in pyruvate by AOA in livers perfused with lactate This in tissue pyruvate is the of the redox by AOA also that α-ketoglutarate and adducts with AOA We of in the of livers perfused with lactate AOA ± and pyruvate AOA ± the α-ketoglutarate and adducts they and α-ketoglutarate and in liver it is that concentrations of AOA adducts with α-ketoglutarate and in livers perfused with and in the livers of with these adducts exert metabolic effects is our of the the formation of adducts AOA and in liver previously We also that with pyruvate to an by the as an with pyruvate Annu. Rev. Biochem. PubMed Scopus Google Scholar). this we pyruvate or with and diethyl and analysis the and of its the time of formation of lactate, the as the AOA adducts using the were the formation is Also, we could the in the of livers perfused with lactate the we could the formation of adducts and α-ketoglutarate or In our data show that of in livers perfused with lactate, the of pyruvate. of AOA and α-ketoglutarate or with formation of were The formation of adducts may affect the concentrations of the the of AOA this study, the of our the adducts and AOA may exert metabolic effects that formation results in a of of the liver. our data show a GNG and the from the liver of gluconeogenic compounds to the CAC intermediates, and of these intermediates was observed in the liver of in which liver PEPCK was by Yang J. R.A. Kalhan S.C. Hanson R.W. Nutr. Metab. 2005; Scopus Google Scholar). Although these of liver PEPCK a and from renal GNG for the of liver GNG from acids and lactate S.C. M. M.A. PubMed Scopus Google Scholar). This that of the of the to whole GNG in the C. J.M. 1999; PubMed Scopus Google Scholar, K. Chandramouli V. Kumaran K. Schumann W.C. Wahren J. Landau B.R. J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar) is by a of gluconeogenic from In of this is the study that the perfused rat a the perfused rat liver of to and of to glucose J.M. H.A. Biochem. J. PubMed Scopus Google Scholar). We testing this

References

43